AGFA Gevaert NV (AGFB)

Currency in EUR
0.63
0.00(0.00%)
Closed·
AGFB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.630.64
52 wk Range
0.611.18
Key Statistics
Prev. Close
0.63
Open
0.63
Day's Range
0.63-0.64
52 wk Range
0.61-1.18
Volume
89.93K
Average Volume (3m)
134.84K
1-Year Change
-5.97%
Book Value / Share
1.85
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AGFB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.10
Upside
+74.60%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

AGFA Gevaert NV News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

AGFA Gevaert NV Company Profile

Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems worldwide. It operates through four segments: HealthCare IT, Digital Print and Chemicals, Radiology Solutions, and Contractor Operations and Services (CONOPS). The Healthcare IT segment provides healthcare’s enterprise imaging platform. The Digital Print & Chemicals segment offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billboards, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry; and printable synthetic papers and films for graphics, non-destructive testing, aerial photography, and printed circuit board production. The Radiology Solutions segment provides analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. This segment also offers SmartXR that provides radiographers with predictive workflow assistance which includes digital radiography tools for dose, alignment, patient positioning, image rotation, and others. The CONOPS segment engages in supply of film and chemicals, as well support services. It sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.

Employees
4765
Market
Belgium

AGFA Gevaert NV Earnings Call Summary for Q3/2025

  • AGFA Gevaert reported a 7% revenue decline in Q3 2025, with adjusted EBITDA falling to €5 million (down €10 million YoY), triggering an 8.33% stock price drop to €0.77.
  • Despite revenue challenges, the company reduced net financial debt by €20 million and improved working capital by €16 million, with free cash flow reaching €21 million.
  • Healthcare IT is transitioning to cloud/SaaS models, while digital printing faces market slowdown, particularly in North America, and declining radiology demand in China.
  • CEO Pascal Juéry stated the company is 'well positioned to grab SaaS contracts' despite short-term impacts and announced additional cost-cutting measures for upcoming quarters.
  • Management guidance indicates performance slightly below last year's levels, with moderate top-line growth expected in digital printing and potential site redevelopment in Marseille.
Last Updated: 13/11/2025, 12:30
Read Full Transcript

Compare AGFB to Peers and Sector

Metrics to compare
AGFB
Peers
Sector
Relationship
P/E Ratio
−1.4x−3.9x−0.6x
PEG Ratio
0.020.030.00
Price/Book
0.3x2.2x2.6x
Price / LTM Sales
0.1x4.3x3.3x
Upside (Analyst Target)
74.6%63.4%41.2%
Fair Value Upside
Unlock5.6%4.8%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.10
(+74.60% Upside)

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.12 / -0.03
Revenue / Forecast
257.00M / 278.90M
EPS Revisions
Last 90 days

AGFB Income Statement

People Also Watch

11.85
BAR
+0.34%
6.22
ONTEX
+1.47%
9.37
AZE
-0.21%
23.77
DAST
+1.19%
858.80
ASML
+2.97%

FAQ

What Stock Exchange Does AGFA Gevaert Trade On?

AGFA Gevaert is listed and trades on the Brussels Stock Exchange stock exchange.

What Is the Stock Symbol for AGFA Gevaert?

The stock symbol for AGFA Gevaert is "AGFB."

What Is the AGFA Gevaert Market Cap?

As of today, AGFA Gevaert market cap is 97.23M.

What Is AGFA Gevaert's Earnings Per Share (TTM)?

The AGFA Gevaert EPS (TTM) is -0.40.

When Is the Next AGFA Gevaert Earnings Date?

AGFA Gevaert will release its next earnings report on 10 Mar 2026.

From a Technical Analysis Perspective, Is AGFB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has AGFA Gevaert Stock Split?

AGFA Gevaert has split 1 times.

How Many Employees Does AGFA Gevaert Have?

AGFA Gevaert has 4765 employees.

What is the current trading status of AGFA Gevaert (AGFB)?

As of 25 Nov 2025, AGFA Gevaert (AGFB) is trading at a price of 0.63, with a previous close of 0.63. The stock has fluctuated within a day range of 0.63 to 0.64, while its 52-week range spans from 0.61 to 1.18.

What Is AGFA Gevaert (AGFB) Price Target According to Analysts?

The average 12-month price target for AGFA Gevaert is EUR1.1, with a high estimate of EUR1.2 and a low estimate of EUR1. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +74.60% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.